Here’s how the pause in the medical device tax has been a boon
The president and CEO of AdvaMed appeared at MedCity News's CONVERGE conference in Philadelphia to spell out how exactly the device tax suspension has benefitted its members.
Why medtech must go digital: ‘You can’t bring a knife to a gunfight’
The medtech industry must catch up with Silicon Valley in terms of integrating digital tools into healthcare devices - or risk being overshadowed by the tech giants, a panel of venture capitalists said at this week's AdvaMed 2015 conference in San Diego.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
J&J’s medtech arm partnering out, pushing innovation agenda
Johnson & Johnson's medtech leadership is interested in partnering out, and wants the startup world to know.
EY Report: With early stage investing stifled, things look grim for the medical device industry
The lack of innovation in the medical device industry can be attributed to the lessening dollars being funneled into startups, a new report from Ernst & Young says.
FCC + FDA: Working together to regulate digital health
The FCC and FDA are working together to regulate digital health - meeting every four months to discuss interoperability, cybersecurity and wireless health.
Digital health and medical device trends (your Health 2.0, AdvaMed previews) on MedHeads
Brace yourselves: Matt Holt joins the panel.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Going generic: Should medical device companies ditch the incremental upgrades?
Premier CEO Susan DeVore ruffled a few audience feathers at this week’s AdvaMed conference in Chicago when she said that innovation done on an incremental basis drives costs up – so medical device companies should just go generic. It’ll level the playing field, she argued, and then companies can direct their dollars to hit upon a technology that’s […]
Hospital bottom lines: Why clinical trial enrollment is abysmal
To help reshape the severely flawed U.S. clinical trial system (see above), physicians need better incentives to enroll their patients, said Dr. Roxana Mehran, a cardiology professor hailing from Icahn School of Medicine. Here’s why: Fifteen percent of clinical trial sites don’t enroll patients at all, Mehran said at this week’s AdvaMed conference in Chicago. On the flip side, […]
Can chocolate bars with silver nanoparticles cure Ebola? FDA Commissioner riffs on fraud
U.S. regulators have come across some serious quackery when it comes to Ebola treatments: Take, for instance, the chocolate bar filled with silver nanoparticles touted to treat the deadly virus, FDA Commissioner Margaret Hamburg said at this week’s Advamed conference in Chicago. She’s also seen a marijuana constituent that’s “guaranteed to cure Ebola” – products […]
FDA Commissioner tackles medical device outsourcing to Europe – and gets a pointed rebuttal
Serious U.S. regulatory lags are driving the medical device business to Europe – with startups, clinical trial sites and market approvals all migrating eastward at a rapid clip. At the same time, the Food and Drug Administration has stated it has the vision for the U.S. to be the world’s leader in medical device innovation and manufacture. […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
E&Y Report: Medtech holds steady, but price concerns outpace design for customers
One underlying trend in the medtech industry is a shift toward commoditization if it doesn’t start mixing up the product offerings, led Ernst & Young’s latest pulse of the industry analysis, which it released today at the Advamed conference in Chicago. “As purchasing decisions become increasingly centralized and influence shifts from physicians to hospital administrators and managers, the historical value […]
The sky IS falling for medical devices. But is that a disaster or a rainmaker?
Understatement of the week: There’s a bit of a clash of opinion when it comes to the medical device tax at the AdvaMed 2014 conference this week in Chicago. Namely, the trade group’s staunchly clinging to the opinion that it’s pretty much a disaster. But other sources at the conference, including the folks over EvaluateMedTech who released a […]
Here’s your preview of the medtech companies at Advamed 2014
Today marks the kickoff of Advamed 2014 – the country’s premiere med tech conference in which gaggles of device companies (2,500 attendees) congregate in Chicago’s McCormick Place. The conference examine topics like regulatory and reimbursement strictures, legal and IP law, marketing, quality, compliance and other key responsibilities as they apply to the medical device sector. Hillary Clinton’s […]
Understanding interactions between physicians and biopharmaceutical and medical technology professionals
As the Centers for Medicare and Medicaid Services (CMS) works to develop a searchable public website for reported “transfers of value” from health industry manufacturers to physicians and teaching hospitals, as required under the 2010 physician payment (Sunshine) law, the requirement for “background information on industry-physician relationships” deserves significant attention. Appropriate background information will be […]
Startup Jobs and Innovation Act could mean big break for life sciences industry
Could a new bill in the U.S. Senate jumpstart healthcare startups? Sen. Robert Menendez (D-N.J.) and Sen. Pat Toomey (R-Penn.) introduced the Startup Jobs and Innovation Act today. If turned into law, the legislation would modify the tax code to allow innovative startups to partner with investors through “R&D Partnership Structures.” This could mean a break […]